Introducing inhibitors of bone morphogenic proteins along with basic fibroblast growth factor (bFGF) into culture medium for human embryonic stem (ES) cells facilitates long-term maintenance of these cells in the pluripotent state, coming one step closer to the goal of a fully defined system for human ES cell (hESC) culture free of animal products.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Xu, R.H. et al. Nat. Methods 2, 185–191 (2005).
Amit, M. et al. Dev. Biol. 227, 271–278 (2000).
Xu, C. et al. Nat. Biotechnol. 19, 971–974 (2001).
Xu, R.H. et al. Nat. Biotechnol. 20, 1261–1264 (2002).
Pera, M.F. et al. J. Cell. Sci. 117, 1269–1280 (2004).
Ying, Q.L., Nichols, J., Chambers, I. & Smith, A. Cell 115, 281–292 (2003).
Pera, M.F. & Trounson, A.O. Development 131, 5515–5525 (2004).
Vallier, L., Reynolds, D. & Pedersen, R.A. Dev. Biol. 275, 403–421 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pera, M. Stem cell culture, one step at a time. Nat Methods 2, 164–165 (2005). https://doi.org/10.1038/nmeth0305-164
Issue Date:
DOI: https://doi.org/10.1038/nmeth0305-164
This article is cited by
-
Embryonic stem cells as a source of models for drug discovery
Nature Reviews Drug Discovery (2007)
